Literature DB >> 20010554

The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.

E P Brass1.   

Abstract

Mesh：

Year:  2009        PMID： 20010554     DOI： 10.1038/clpt.2009.218

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  12 in total

1.  Prioritization in comparative effectiveness research: the CANCERGEN Experience.

Authors:  Rahber Thariani; William Wong; Josh J Carlson; Louis Garrison; Scott Ramsey; Patricia A Deverka; Laura Esmail; Sneha Rangarao; Carolyn J Hoban; Laurence H Baker; David L Veenstra
Journal:  Med Care       Date:  2012-05       Impact factor: 2.983

2.  Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.

Authors:  Valerie Carreau; Jean-Philippe Girardet; Eric Bruckert
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

3.  The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.

Authors:  Cécile Droz-Perroteau; Caroline Dureau-Pournin; Hervé Vespignani; Cécile Marchal; Patrick Blin; Sylvie Blazejewski; Clothilde Pollet; Jérémy Jové; Philip Robinson; Nicholas Moore; Annie Fourrier-Réglat
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

4.  The feasibility of a clinical trial of pain related to temporomandibular muscle and joint disorders: the results of a survey from the Collaboration on Networked Dental and Oral Research dental practice-based research networks.

Authors:  Ana M Velly; Eric L Schiffman; D Brad Rindal; Joana Cunha-Cruz; Gregg H Gilbert; Maryann Lehmann; Allan Horowitz; James Fricton
Journal:  J Am Dent Assoc       Date:  2013-01       Impact factor: 3.634

5.  How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia.

Authors:  Francesca Galeotti; Nicola Vanacore; Sabina Gainotti; Fabio Izzicupo; Francesca Menniti-Ippolito; Carlo Petrini; Flavia Chiarotti; Rabih Chattat; Roberto Raschetti
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 6.  Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.

Authors:  Li-Shiun Chen; Laurie Zawertailo; Thomas M Piasecki; Jaakko Kaprio; Marilyn Foreman; Hannah R Elliott; Sean P David; Andrew W Bergen; James W Baurley; Rachel F Tyndale; Timothy B Baker; Laura J Bierut; Nancy L Saccone
Journal:  Nicotine Tob Res       Date:  2018-03-06       Impact factor: 4.244

7.  Embedding clinical trials in clinical practice: Harvesting experience and winnowing evidence.

Authors:  Arun S Nanivadekar
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

8.  Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.

Authors:  Y W Francis Lam
Journal:  ISRN Pharmacol       Date:  2013-02-28

9.  Open access capture of patients with gastroesophageal reflux disease using an online patient-reported outcomes instrument.

Authors:  Merel M Tielemans; Jan Bmj Jansen; Martijn Gh van Oijen
Journal:  Interact J Med Res       Date:  2012-09-26

10.  Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial.

Authors:  Alexios Politis; Vasileios Ioannidis; Konstantinos I Gourgoulianis; Zoe Daniil; Chrissi Hatzoglou
Journal:  Chron Respir Dis       Date:  2017-11-08       Impact factor: 2.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.